461 related articles for article (PubMed ID: 34639352)
21. Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: Focused literature review.
Madzima TR; Vahabi M; Lofters A
Can Fam Physician; 2017 Aug; 63(8):597-601. PubMed ID: 28807952
[TBL] [Abstract][Full Text] [Related]
22. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
23. Reasons for non-attendance to cervical cancer screening and acceptability of HPV self-sampling among Bruneian women: A cross-sectional study.
Chaw L; Lee SHF; Ja'afar NIH; Lim E; Sharbawi R
PLoS One; 2022; 17(3):e0262213. PubMed ID: 35287163
[TBL] [Abstract][Full Text] [Related]
24. Preliminary assessment of using mobile point-of-care human papillomavirus (HPV) testing with the option of immediate colposcopy in a rural area in a high-income country: a case study.
Paterson H; Macfarlane E; Slater T; Stanton JL; MacDonald EJ; Gibson M; Lawton B
N Z Med J; 2024 Jun; 137(1596):43-51. PubMed ID: 38843549
[TBL] [Abstract][Full Text] [Related]
25. Out-reach Colposcopy Clinics and HPV Self-Sampling Decreases Loss to Follow up in a Community based Cervical Cancer Screening Programme.
Thasneem P; Sudhager A; Nalini C; J SSR; Bharathipriya R; Sridharan V; Balasubramani L
Asian Pac J Cancer Prev; 2024 Feb; 25(2):419-424. PubMed ID: 38415526
[TBL] [Abstract][Full Text] [Related]
26. Design of a pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake in a U.S. healthcare system: The STEP trial.
Winer RL; Lin J; Anderson ML; Tiro JA; Meenan RT; Hansen K; Gao H; Sparks A; Greene DN; Kilgore-Martin S; Green BB; Buist DSM
Contemp Clin Trials; 2022 Nov; 122():106960. PubMed ID: 36241145
[TBL] [Abstract][Full Text] [Related]
27. "The best thing is that you are doing it for yourself" - perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study.
Bakiewicz A; Rasch V; Mwaiselage J; Linde DS
BMC Womens Health; 2020 Mar; 20(1):65. PubMed ID: 32234028
[TBL] [Abstract][Full Text] [Related]
28. Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis.
Gottschlich A; Rivera-Andrade A; Bevilacqua K; Murchland AR; Isak E; Alvarez CS; Ogilvie G; Carey TE; Prince M; Dean M; Mendoza-Montano C; Meza R
BMC Public Health; 2020 Sep; 20(1):1406. PubMed ID: 32933512
[TBL] [Abstract][Full Text] [Related]
29. Perspectives of women participating in a cervical cancer screening campaign with community-based HPV self-sampling in rural western Kenya: a qualitative study.
Oketch SY; Kwena Z; Choi Y; Adewumi K; Moghadassi M; Bukusi EA; Huchko MJ
BMC Womens Health; 2019 Jun; 19(1):75. PubMed ID: 31196175
[TBL] [Abstract][Full Text] [Related]
30. Retrospective survey of colposcopy experience for wāhine Māori across two time periods (2016 and 2021) in Waitematā and Auckland districts, New Zealand.
Bartholomew K; Aye PS; Griffiths V; Schaapveld T; Gingell M; Hart S; Chambers E; Metekingi M; Baty B; McPherson G; Flower D
N Z Med J; 2023 Oct; 136(1584):10-26. PubMed ID: 37856751
[TBL] [Abstract][Full Text] [Related]
31. A pilot study of community-based self-sampling for HPV testing among non-attenders of cervical cancer screening programs in El Salvador.
Laskow B; Figueroa R; Alfaro KM; Scarinci IC; Conlisk E; Maza M; Chang JC; Cremer M
Int J Gynaecol Obstet; 2017 Aug; 138(2):194-200. PubMed ID: 28589548
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness and feasibility of self-sampling for human papillomavirus testing for internet-based cervical cancer screening.
Li J; Wu R; Qu X; Huang X; Li L; Lin Z; Zhang Z; Deng J; Liu R; Zhao X; Zhang S; Lin B; An R; Zhao C; Li M; Zhao Y; Wei L
Front Public Health; 2022; 10():938272. PubMed ID: 36420004
[TBL] [Abstract][Full Text] [Related]
33. Experience and acceptability for HPV self-sampling among women in Jiangsu province, China: a cross-sectional survey.
Qu SX; Ni YH; Qin JF; Chen XY; Wu WL; Zhang WC
J Obstet Gynaecol; 2023 Dec; 43(1):2204942. PubMed ID: 37129887
[TBL] [Abstract][Full Text] [Related]
34. Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: Example from New Zealand.
Smith MA; Hall M; Lew JB; Canfell K
Vaccine; 2018 Oct; 36(42):6314-6324. PubMed ID: 30224201
[TBL] [Abstract][Full Text] [Related]
35. Feasibility of HPV self-sampling pathway in Kathmandu Valley, Nepal using a human-centred design approach.
Shrestha S; Thapa S; Sims P; Ardelean A; Basu A; Caws M; Gurung SC; Holdsworth G
Sex Reprod Health Matters; 2021; 29(3):2005283. PubMed ID: 34928198
[TBL] [Abstract][Full Text] [Related]
36. Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study.
Bertucci M; Bonnet E; Satger L; Kreiche A; Chappert JL; Loy-Morel S; Segondy M; Daurès JP; Boulle N
Women Health; 2021 Jan; 61(1):83-94. PubMed ID: 33106125
[TBL] [Abstract][Full Text] [Related]
37. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
38. Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe.
Fitzpatrick M; Pathipati MP; McCarty K; Rosenthal A; Katzenstein D; Chirenje ZM; Pinsky B
BMC Womens Health; 2020 Jul; 20(1):153. PubMed ID: 32711530
[TBL] [Abstract][Full Text] [Related]
39. Implementation of a Cervical Cancer Screening Intervention for Under- or Never-Screened Women in Ontario, Canada: Understanding the Acceptability of HPV Self-Sampling.
Devotta K; Vahabi M; Prakash V; Lofters AK
Curr Oncol; 2023 Jul; 30(7):6786-6804. PubMed ID: 37504357
[TBL] [Abstract][Full Text] [Related]
40. Perceived barriers to self-collected HPV testing for cervical cancer screening, and knowledge of HPV: a survey of primary healthcare smear-takers across Aotearoa New Zealand.
Ingamells S; Bell R; Nip J; Innes C; Te Whaiti S; Tino A; McBain L; McMenamin J; Hudson B; Gibson M; Lawton B; Sykes P
N Z Med J; 2024 Feb; 137(1590):57-76. PubMed ID: 38386856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
